Literature DB >> 17979491

An extranodal nasal natural killer/T-cell lymphoma with isochromosome 7q10 as the sole cytogenetic aberration was initially diagnosed via bone marrow biopsy.

Huan-You Wang1, Kathleen S Wilson, Robert W McKenna, Yin Xu, Nitin Karandikar.   

Abstract

We report a 58-year-old man who presented with fever, pancytopenia, hepatosplenomegaly, and "sinusitis" of his right nostril. Flow cytometric analysis of his bone marrow aspirate revealed a population of cells that were CD56+ (bright), CD2+ (dim), and CD7+ (slight brightly) but negative for CD3, CD4, CD5, CD8, CD11b, CD16, CD57, and T-cell receptors, consistent with aberrant natural killer cells. Bone marrow biopsy showed an atypical lymphoid infiltrate expressing CD56 as well as Epstein-Barr virus- encoded RNA and histiocytic hyperplasia with hemophagocytosis. Subsequent biopsy of his right nasal vestibule demonstrated an atypical lymphoid infiltrate, which was cytoplasmic CD3+, CD56+, and Epstein-Barr virus-encoded RNA positive, consistent with an extranodal nasal natural killer cell lymphoma. Conventional cytogenetic studies of the bone marrow revealed isochromosome 7q10 [i(7)(q10)] as the sole chromosomal aberration. To our knowledge, this is the first report demonstrating i(7)(q10) as a primary cytogenetic abnormality in an extranodal nasal natural killer cell lymphoma.

Entities:  

Mesh:

Year:  2007        PMID: 17979491     DOI: 10.5858/2007-131-1709-AENNTL

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  2 in total

1.  Extranodal NK/T-cell lymphoma, nasal type extensively involving the bone marrow.

Authors:  Sherif A Rezk; Qin Huang
Journal:  Int J Clin Exp Pathol       Date:  2011-10-10

2.  Extranodal NK/T Cell Lymphoma of the Jejunum Complicated by Hemophagocytic Syndrome: Practical Problems Encountered by a Pathologist.

Authors:  Jinkala Sree Rekha; Rakhee Kar; Sajini Elizabeth Jacob; Neelaiah Siddaraju; Bettadpura Shamana Suryanarayana; Molly Mary Thabah; Rakesh Naik; Nanda Kishore Maroju
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-24       Impact factor: 0.900

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.